ZAEL VAZQUEZ, M.D. – MEDICAL DIRECTOR
Dr. Zael Vazquez was born in Havana, Cuba. He joined Mario Magcalas, M.D., P.A. on September 15, 2014.
He finished in Associate in Arts at the Miami Dade Community College Pre Medical Sciences with the Highest Honors. He finished Bachelor of Science at the University of Florida in Gainesville, FL – Microbiology and Cell Sciences Chemistry Minor.
He finished his medical school with the medical degree at the Ross University, School of Medicine in North Brunswick, NJ.
Dr. Vazquez had his Internship and Residency at the Hahnemann University Hospital, affiliated with Drexel University School of Medicine, Philadelphia, PA.
At the Temple University Hospital in Philadelphia, PA, he was highly trained in the following specialties: Thoracic Sonography and Endobronchial Ultrasound and Pulmonary and Critical Care Medicine from July 2010 to June 30, 2014.
Some of Dr. Vazquez’s presentations and publications that he co-authored are the following:
- Geographic Variability in Hospital Readmission Rates and Mortality among Pennsylvania Patients with COPD.
- The Implementation of the Lung Allocation Score Improves Post-transplant Survival in Patients with Idiopathic Pulmonary Fibrosis.
He is Board Certified in Internal Medicine and will be sitting for his Board exam in Pulmonary Diseases in November 2015.
He is a member of the American Board of International Medicine.
NELSON NORBERTO ALDANA, M.D.
Dr. Nelson N. Aldana was born in Medellin, Colombia. He joined Mario Magcalas, M.D., P.A. on November 27, 2017.
He finished his medical school with the Medical Degree at the National University of Colombia, Bogotá, Colombia.
Dr. Aldana had his Residency at the Mount Sinai Medical Center, Miami Beach, FL.
At the Rush Univeristy Hospital / John H. Stroger Jr. Hospital of Cook County, Chicago, IL, he was highly trained in the following specialties: Pulmonary and Critical Care Medicine from 2012 to 2015.
Some of Dr. Aldana’s presentations and research activities that he participated:
- A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter CLinical Study Evaluating the Safety and Efficacy of Icatibant as a Treatment for Angiotensin-Converting Enzyme Inhibitor (ACE-I)-Induced Angioedema in Adults.
- Effect of Pulmonary Rehabilitation on 6-Minute Walk Distance in Sarcoidosis and other Interstitial Lung Diseases in comparison with COPD: The Cook County Experience.
He is board certified in Internal Medicine, Pulmonary Diseases and Critical Care Medicine. He has been a Diplomate of the American Board of Internal Medicine in October 2010, American Board of Medical Specialties, Pulmonary Diseases in November 2014 and Critical Care Medicine in October 2015.